Peptide Modulation of Silver Diamine Fluoride Derivatives in Dentin
Researchers investigated peptide modulators for dental applications to transition from passive treatment to actively designing the biological interface with specific responses for efficacy and minimal off-target effects.
The study examined the use of silver diamine fluoride (SDF) modulating peptides to address limitations in current cavity management strategies. While SDF has been effective for early childhood caries, its universal application is constrained by permanent black staining on treated tissues. This research explores how peptide modulators can direct desired biological outcomes at the interface of dental bioceramic tissues while mitigating these aesthetic drawbacks.
Human dentin tissue slabs were treated with SDF alone or SDF followed by a silver diamine fluoride modulating peptide (SDF-ModP). The researchers employed Raman micro-spectroscopy and X-ray photoelectron spectroscopy to identify the specific silver compounds formed during treatment. Color changes were monitored over time using the CIELAB color space to quantify staining outcomes.
Analysis identified silver chloride, silver (I) oxide, and silver (II) oxide as the most abundant compounds in SDF-treated dentin. XPS deconvolution confirmed the coexistence of metallic silver, Ag (I), and Ag (III) species. The SDF-ModP treatment modulated the distribution of these species, reducing both metallic silver and Ag (III) oxide formation while increasing the proportion of Ag (I) compounds.
Over a 7-day monitoring period, time-resolved color analysis revealed that SDF-ModP delayed and reduced overall black staining compared to SDF alone. The peptide modulated silver chemistry by reducing the formation rate of metallic silver chromophores and higher-valence oxides, thereby decreasing dentin discoloration. These findings suggest that SDF-modulating peptides can improve therapeutic efficacy and esthetic outcomes of SDF therapy.
This approach represents a molecular biomimetic engineering strategy in which specific peptide interactions with metal ions modulate the biological interface. While these results demonstrate potential for controlling metal ion speciation, further research is needed to establish clinical protocols and long-term safety profiles. The findings are presented as a laboratory investigation into material modification rather than a clinical recommendation.